MyAmyloidosisTeam

Based on the provided search results, there is not enough specific information to definitively answer whether CyBorD (Cyclophosphamide, Bortezomib, and Dexamethasone) plus Daratumumab affects PSA levels in amyloidosis patients. This would be an excellent question to discuss with your hematologist or oncologist who can Show Full Answer

Based on the provided search results, there is not enough specific information to definitively answer whether CyBorD (Cyclophosphamide, Bortezomib, and Dexamethasone) plus Daratumumab affects PSA levels in amyloidosis patients. This would be an excellent question to discuss with your hematologist or oncologist who can review your specific case and medical history.

While Darzalex Faspro (daratumumab) has received FDA approval for light chain amyloidosis treatment, its effects on PSA are not detailed in the available information. For the most accurate information about how your specific treatment regimen may affect your PSA levels, please consult with your healthcare team. They can monitor your PSA levels before and during treatment to identify any significant changes.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Hepatic Amyloidosis and Its Impact on the Liver

MyAmyloidosisTeam